Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Anthera Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Anthera Pharmaceuticals Inc market cap is $0.00.
What is the 52-week high for Anthera Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anthera Pharmaceuticals Inc 52 week high is $0.001 as of October 27, 2025.
What is the 52-week low for Anthera Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anthera Pharmaceuticals Inc 52 week low is $0.00 as of October 27, 2025.
What is Anthera Pharmaceuticals Inc stock price today?
Anthera Pharmaceuticals Inc stock price today is $0.0001.
What is the 50-day moving average of Anthera Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Anthera Pharmaceuticals Inc 50-day moving average is $0.0002.